The Next Generation Biotech Media
As SARS-CoV-2, the causative agent for COVID-19, continues to cause rampant destruction on human lives globally, biopharma companies are stepping up their game to provide some relief. The latest one …
Read More
The J.P. Morgan Healthcare Conference is an annual pilgrimage for industry leaders, venture capitalists, innovators, and trendsetters who gather at the Westin St. Francis Hotel in San Francisco to make …
Read More
The Philippines government has signed a second vaccine deal to procure 30 million doses of Covovax, the COVID-19 vaccine developed by Novavax. The candidate is developed by the Serum Institute …
Read More
Brazil has the third-largest outbreak of COVID-19 with 8 million cases but is second in fatality rate with 200,000 deaths [1]. With just over 3% of its total population infected, …
Read More
The end of 2020 witnessed two vaccine approvals in the US and UK. One expects to see more such approvals of other candidates in 2021. Meanwhile, two Asian countries have …
Read More
On December 28th, Arcturus Therapeutics announced that it had received authorization from the Singapore Health Sciences Authority to begin Phase 2 clinical trials of their vaccine candidate, ARCT-021, against COVID-19. …
Read More
India, a country with the second-highest number of infections globally, becomes third after the UK and Argentina to grant emergency approval to the COVID-19 vaccine jointly developed by AstraZeneca and …
Read More
With record timing and pushing through precedents in the fields of biomanufacturing and immunology, many private enterprises have come out with vaccines for the Coronavirus. As a result of this …
Read More
It has been a year to remember. A year that has reminded us of the dangers of negligence and how little lapses can trigger a global crisis of massive proportions. …
Read More
December 30th, 2020 – After a long and dark year of multiple waves of the COVID-19 outbreak, the first vaccines made it to the market in December 2020. In the …
Read More